C4 Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.

CEO

Andrew J. Hirsch

CEOAndrew J. Hirsch

Employees

110

Employees110

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2015

Founded2015

Employees

110

Employees110

CCCC Key Statistics

Market cap

165.09M

Market cap165.09M

Price-Earnings ratio

-1.48

Price-Earnings ratio-1.48

Dividend yield

—

Dividend yield—

Average volume

1.94M

Average volume1.94M

High today

$2.71

High today$2.71

Low today

$2.20

Low today$2.20

Open price

$2.24

Open price$2.24

Volume

3.95M

Volume3.95M

52 Week high

$7.36

52 Week high$7.36

52 Week low

$1.09

52 Week low$1.09

Analyst ratings

67%

of 6 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own CCCC. This list is generated using Robinhood data, and it’s not a recommendation.